Anvendelse af Rapamune til nyretransplanterede patienter var forbundet med forhøjet serum - kolesterol og - triglycerid, som kan kræve behandling.
The use of Rapamune in renal transplant patients was associated with increased serum cholesterol and triglycerides that may require treatment.